CN Patent

CN112645929B — 异丙磺酰基苯基嘧啶类化合物或其盐的多晶型物

Assigned to Suzhou Zelgen Biopharmaceutical Co Ltd · Expires 2022-03-11 · 4y expired

What this patent protects

本发明提供了一种异丙磺酰基苯基嘧啶类化合物或其盐的多晶型物，具体地，涉及5‑氯‑N 2 ‑(5‑甲基‑4‑(哌啶‑4‑基)‑2‑((丙‑2‑基‑d 7 )氧基)苯基)‑N 4 ‑(2‑((丙‑2‑基‑d 7 )磺酰基)苯基)嘧啶‑2,4‑二胺或其盐酸盐的多晶型物。所述多晶型物方便加工、适合成药，适于制备抑制酪氨酸激酶(如ALK激酶和ROS1激酶)的药物或药物组合物。

USPTO Abstract

本发明提供了一种异丙磺酰基苯基嘧啶类化合物或其盐的多晶型物，具体地，涉及5‑氯‑N 2 ‑(5‑甲基‑4‑(哌啶‑4‑基)‑2‑((丙‑2‑基‑d 7 )氧基)苯基)‑N 4 ‑(2‑((丙‑2‑基‑d 7 )磺酰基)苯基)嘧啶‑2,4‑二胺或其盐酸盐的多晶型物。所述多晶型物方便加工、适合成药，适于制备抑制酪氨酸激酶(如ALK激酶和ROS1激酶)的药物或药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN112645929B
Jurisdiction
CN
Classification
—
Expires
2022-03-11
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Zelgen Biopharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.